Skip to main content
Investors
Scibase.com
Open menu
At a Glance
Open link menu
At a Glance
Investment Case
Our Strategy
Market Overview
Results & Reports
Open link menu
Results & Reports
Calendar
Financial Data
The Share
Open link menu
The Share
Shareholders
Insider Transactions
Analysts
Prospectus Regarding Shares
Share Capital Development
Warrants
Governance
Open link menu
Governance
Management and Board of Directors
Annual General Meeting
Articles of Association
Auditor
Certified Advisor
Committees
ESG - sustainability
Releases
Open link menu
Releases
Subscription Service
EN
Current language English, click to switch language
SV
Switch to Svenska
Search
Search
Search
Search on a site
Please fill out this field
Back
Close menu
Search on a site
Please fill out this field
Close
Oct 26 2022
New study shows Nevisense significantly improves US clinician's decision-making beyond dermoscopy
May 18 2022
Annual general meeting has been held in SciBase Holding AB (publ)
Aug 09 2022
FDA expert panel in line with SciBase position to keep stringent approval level for all new skin lesion analyzers
Aug 18 2022
Interim report
May 10 2022
SciBase to present at the Redeye Medtech & Diagnostics Seminar on May 11, 2022
May 12 2022
Interim Report Q1 2022
May 16 2022
US study shows that EIS and Nevisense significantly improves clinicians' diagnostic accuracy
Apr 13 2022
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN SCIBASE HOLDING AB (PUBL)
Apr 22 2022
SciBase publishes the Annual report for 2021
Apr 29 2022
German study shows clinical benefit of Nevisense
Pagination
First page
Previous page
…
Page
13
Page
14
Page
15
Page
16
Current page
17
Page
18
Page
19
Page
20
Page
21
…
Next page
Last page
Subscribe to
Close popup
Left
Right
